Premium Nahrungsergänzungsmittel | artgerecht

Collagen Resorption Markers – Definition & Meaning

Collagen resorption markers are laboratory values that indicate bone breakdown. They help doctors detect and monitor osteoporosis and other bone diseases at an early stage.

Regular tips about health Regular tips about health

Things worth knowing about "Collagen resorption markers"

Collagen resorption markers are laboratory values that indicate bone breakdown. They help doctors detect and monitor osteoporosis and other bone diseases at an early stage.

What Are Collagen Resorption Markers?

Collagen resorption markers are biochemical parameters measured in blood or urine that reflect the breakdown of collagen in the body. Since bone tissue consists largely of collagen type I, these markers primarily indicate the rate of bone resorption (bone breakdown). They are used in clinical diagnostics to detect conditions such as osteoporosis, Paget's disease of bone, or bone-metastasizing cancers, and to monitor the effectiveness of treatment.

Biological Background

Bone is a living tissue that undergoes continuous remodeling. In this process, specialized cells called osteoclasts break down old bone tissue, while osteoblasts build new bone. During the degradation of collagen type I, specific breakdown products are released into the bloodstream and excreted via the kidneys. These breakdown products are referred to as collagen resorption markers.

Key Collagen Resorption Markers

CTX (C-terminal Telopeptide)

The Beta-CrossLaps test (Beta-CTX) measures fragments of the C-terminal telopeptide of collagen type I. It is considered one of the most sensitive and widely used markers for bone resorption. Blood is collected in the morning in a fasting state for the most reliable results.

NTX (N-terminal Telopeptide)

The N-terminal telopeptide (NTX) is another breakdown marker of collagen type I. It can be measured in both urine and blood and provides similar information to the CTX value.

DPD (Deoxypyridinoline) and PYD (Pyridinoline)

Deoxypyridinoline (DPD) and pyridinoline (PYD) are cross-linking molecules of collagen that are released during bone resorption. They are mainly measured in urine and normalized to creatinine to compensate for diurnal fluctuations.

TRACP-5b (Tartrate-Resistant Acid Phosphatase)

TRACP-5b is an enzyme secreted by active osteoclasts and can also serve as a marker of elevated bone resorption.

Clinical Applications

Osteoporosis: Monitoring bone breakdown and assessing therapeutic response to anti-osteoporotic medications (e.g., bisphosphonates)
Paget's disease of bone: Follow-up of elevated bone turnover
Bone metastases: Indication of increased bone breakdown in cancer patients
Hyperparathyroidism: Evaluation of elevated blood calcium levels
Therapy monitoring: Assessment of response to bone-active therapies

Testing and Influencing Factors

For reliable measurement, blood should be drawn in the morning in a fasting state, as collagen resorption markers – especially CTX – are subject to pronounced circadian and food-related fluctuations. The following factors can influence measured values:

Time of day and food intake
Age and sex (postmenopausal women often show elevated values)
Physical activity
Kidney function (impaired kidney function may elevate marker levels)
Medication use (e.g., glucocorticoids, bisphosphonates)

Interpretation of Results

Elevated collagen resorption markers indicate increased bone breakdown. However, they are not a standalone diagnostic criterion and must always be interpreted in the context of other investigations (e.g., bone density measurement, imaging, clinical picture). Reference ranges vary by laboratory, age, and sex of the patient. An isolated elevation of a single marker is not sufficient to establish a diagnosis.

References

Eastell R. et al. - Diagnosis of Endocrine Disease: Bone turnover markers: are they clinically useful? European Journal of Endocrinology, 2018.
Vasikaran S. et al. - Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporosis International, 2011.
World Health Organization (WHO) - Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, WHO Technical Report Series, 1994.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category